The Mecholyl Test in Schizophrenia
Abstract
Reports in the literature on the Mecholyl test suggest that schizophrenics with a marked reaction to Mecholyl tend to be acute cases with good prognoses, demonstrating relatively good adjustment both preceding and during the psychosis. Schizophrenics with a mild Mecholyl reaction tend to be chronic and/or poor prognostic risks and manifest grossly inadequate premorbid as well as current functioning. The authors note conflicting evidence and identify the problem of test reliability as a primary source of ambiguous data.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
